In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Humacyte Inc (NASDAQ: HUMA) closed at $2.62 in the last session, down -1.87% from day before closing price of $2.67. In other words, the price has decreased by -$1.87 from its previous closing price. On the day, 4.52 million shares were traded.
Ratios:
We take a closer look at HUMA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.28 and its Current Ratio is at 3.68. In the meantime, Its Debt-to-Equity ratio is 2.28 whereas as Long-Term Debt/Eq ratio is at 2.15.
On December 20, 2024, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $12 to $15.
On December 11, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $6.H.C. Wainwright initiated its Buy rating on December 11, 2023, with a $6 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 14 ’25 when Scheessele William John bought 6,493 shares for $1.54 per share. The transaction valued at 9,999 led to the insider holds 22,018 shares of the business.
Sander Dale A. bought 20,000 shares of HUMA for $30,600 on Apr 10 ’25. The CFO and Chief Corp. Deve. Off. now owns 40,600 shares after completing the transaction at $1.53 per share. On Apr 10 ’25, another insider, Parikh Shamik J, who serves as the Chief Medical Officer of the company, bought 7,500 shares for $1.55 each. As a result, the insider paid 11,625 and bolstered with 7,500 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 781.57 while its Price-to-Book (P/B) ratio in mrq is 11.28.
Stock Price History:
Over the past 52 weeks, HUMA has reached a high of $9.97, while it has fallen to a 52-week low of $1.15. The 50-Day Moving Average of the stock is 44.23%, while the 200-Day Moving Average is calculated to be -35.18%.
Shares Statistics:
A total of 155.12M shares are outstanding, with a floating share count of 125.75M. Insiders hold about 18.94% of the company’s shares, while institutions hold 39.88% stake in the company.
